TransUnion stock price target raised to $95 from $85 at Barclays

TransUnion (TRU) delivered robust Q2 2025 results, surpassing market expectations with adjusted EPS of $1.08 and revenue of $1.14 billion, prompting an upward revision of its full-year financial guidance. This strong performance led Barclays to raise its price target to $95 (maintaining Equalweight) and Morgan Stanley to $122 (maintaining Overweight), reflecting increased analyst confidence and positive investor sentiment, especially given the stock's 27.4% surge over the past year.

Analysis

TransUnion (TRU) has demonstrated strong operational performance by delivering a solid beat in its Q2 2025 financial results. The company reported adjusted EPS of $1.08 against a forecast of $0.99 and revenue of $1.14 billion, exceeding the anticipated $1.1 billion. This outperformance prompted the company to raise its full-year financial guidance, a move that signals confidence in its ongoing business trajectory. The positive results have been met with favorable analyst actions, though with some divergence in outlook. Morgan Stanley reiterated its Overweight rating and increased its price target to $122 from $120. In contrast, Barclays, while raising its price target to $95 from $85, maintained an Equalweight rating, noting that the revised guidance remains conservative. This suggests that while TRU's execution is strong, as evidenced by a 27.4% stock price increase over the past year, some analysts believe the current valuation may reflect a significant portion of the positive news. Barclays indicates that future stock performance may hinge on clear evidence of product momentum.

Key Decisions for Investors

• Investors should consider the strong fundamental performance, including the earnings beat and raised guidance, which supports the bullish case presented by Morgan Stanley with its $122 price target.
• It is prudent to weigh the significant 27.4% stock appreciation over the past year against the more cautious Equalweight rating from Barclays, whose $95 price target is below the current trading price.
• Monitor for evidence of sustained product momentum, which Barclays has identified as a key potential catalyst for driving more positive sentiment and future stock gains.
• Given that management's raised guidance is viewed as conservative, the company may be well-positioned for future beats, potentially making any price weakness an opportunity for accumulation.